{"schemaVersion":1,"research":true,"symbol":"ame","name":"Ametek","topic":"moat","path":"/stock/ame/moat","status":"published","version":9,"updatedAt":"2026-10-21T18:50:27.090Z","locked":false,"publicFairValue":false,"fairValue":null,"moat":{"verdict":"narrow","summary":"AMETEK has a narrow moat rooted in proprietary technology and differentiated niche products, supported by engineering investment, organic demand growth and firm customer commitments. These establish a current advantage, but do not demonstrate portfolio-wide switching costs, structural cost leadership or exceptional durability. Operating resilience is strong; realized pricing remains unisolated from volume, mix and efficiency. Technological substitution, copying and continued innovation requirements constrain durability. The pending Indicor acquisition adds prospective integration and capital-allocation exposure rather than a demonstrated moat benefit.","advantages":[{"mechanism":"intangible_assets","claim":"Proprietary technology, accumulated engineering capabilities and differentiated niche products support a current, bounded advantage. Reported organic demand growth corroborates commercial relevance, although management's market-share claims lack quantified comparative support.","durability":"Historical engineering spending and continuing product introductions support persistence. Firm orders extending beyond one year provide limited demand visibility, not proof of lasting technological superiority or customer lock-in.","risks":"Markets are highly competitive. Superior competing technology, copying and alternative materials or processes could erode differentiation. Continued development spending is necessary; no patent or trademark group is considered essential.","invalidation":"The thesis would weaken materially if disclosed customer losses or sustained organic order declines were attributable to competing technologies, if comparable substitutes forced recurring price concessions, or if product-development investment ceased producing commercially relevant differentiation.","competitors":[],"evidenceIds":["e1","e2","e3","e4","e11","e12","e13","e14","e15","e18"],"counterEvidenceIds":["e5","e6","e7","e8","e9","e10","e16","e17"]}],"evidence":[{"id":"e1","location":"2025 Form 10-K, filed 2026-02-17; proprietary technology and intellectual-property protection","sourceId":"filing-1","excerpt":"Many of our products rely on proprietary technology; therefore, we endeavor to protect our intellectual property rights through patents, copyrights, trade secrets, trademarks, confidentiality agreements and other contractual provisions."},{"id":"e2","location":"2025 Form 10-K, filed 2026-02-17; niche market-share and differentiation assertion","sourceId":"filing-1","excerpt":"AMETEK maintains strong market share in a number of targeted niche markets through its ability to produce and deliver high-quality, differentiated products at competitive prices."},{"id":"e3","location":"2023 Form 10-K, filed 2024-02-22; 2021–2023 research, development and engineering costs before customer reimbursement","sourceId":"filing-5","excerpt":"Research, development and engineering costs before customer reimbursement were $351.7 million in 2023, $322.1 million in 2022 and $299.6 million in 2021."},{"id":"e4","location":"2025 Form 10-K, filed 2026-02-17; product introductions during 2025","sourceId":"filing-1","excerpt":"In 2025, AMETEK added to its highly differentiated product portfolio with a range of new products across many of its businesses."},{"id":"e5","location":"2025 Form 10-K, filed 2026-02-17; continuing investment required to maintain technological advantages","sourceId":"filing-1","excerpt":"Maintaining our existing technological advantages will require us to continue investing in research and development and sales and marketing."},{"id":"e6","location":"2025 Form 10-K, filed 2026-02-17; competition","sourceId":"filing-1","excerpt":"Competition In general, AMETEK’s markets are highly competitive with competition based on technology, performance, quality, service and price."},{"id":"e7","location":"2025 Form 10-K, filed 2026-02-17; competing technology risk","sourceId":"filing-1","excerpt":"Our competitors may develop new or improve existing products that are superior to our products or may adapt more readily to new technologies or changing requirements of our customers."},{"id":"e8","location":"2025 Form 10-K, filed 2026-02-17; copying and proprietary-rights risk","sourceId":"filing-1","excerpt":"Despite our efforts to protect proprietary rights, unauthorized parties or competitors may copy or otherwise obtain and use our products or technology."},{"id":"e9","location":"2025 Form 10-K, filed 2026-02-17; alternative materials and processes","sourceId":"filing-1","excerpt":"There also is competition from alternative materials and processes."},{"id":"e10","location":"2025 Form 10-K, filed 2026-02-17; limits on essential patent and trademark protection","sourceId":"filing-1","excerpt":"AMETEK, however, does not consider any single patent or trademark, or any group of them, essential either to its business as a whole or to either one of its reportable segments."},{"id":"e11","location":"June 2026 Form 10-Q, filed 2026-08-04; remaining performance obligations beyond one year","sourceId":"filing-2","excerpt":"The remaining performance obligations not expected to be completed within one year as of June 30, 2026 and December 31, 2025 were $747.7 million and $627.4 million, respectively."},{"id":"e12","location":"June 2026 Form 10-Q, filed 2026-08-04; definition of firm, non-cancelable remaining performance obligations","sourceId":"filing-2","excerpt":"Remaining performance obligations represent the transaction price of firm, non-cancelable orders, with expected delivery dates to customers greater than one year from the balance sheet date, for which the performance obligation is unsatisfied or partially unsatisfied."},{"id":"e13","location":"June 2026 Form 10-Q, filed 2026-08-04; expected satisfaction period for remaining performance obligations","sourceId":"filing-2","excerpt":"These performance obligations will be substantially satisfied within two to three years."},{"id":"e14","location":"June 2026 Form 10-Q, filed 2026-08-04; second-quarter order growth separated into organic, acquisition and currency effects","sourceId":"filing-2","excerpt":"The increase in orders for the second quarter of 2026 was due to a 25% increase in organic orders and a 6% increase from acquisitions, partially offset by a 3% unfavorable effect of foreign currency translation."},{"id":"e15","location":"June 2026 Form 10-Q, filed 2026-08-04; second-quarter organic and acquisition sales growth","sourceId":"filing-2","excerpt":"The increase in net sales for the second quarter of 2026 was due to a 10% increase in organic sales, as well as a 5% increase from acquisitions."},{"id":"e16","location":"2024 Form 10-K, filed 2025-02-20; annual order decline and organic, currency and acquisition components","sourceId":"filing-4","excerpt":"The decrease in orders was due to a 2% organic order decrease, a 1% unfavorable effect of foreign currency translation, partially offset by a 2% increase from acquisitions."},{"id":"e17","location":"2024 Form 10-K, filed 2025-02-20; inventory-normalization explanation for organic order decline","sourceId":"filing-4","excerpt":"The organic orders decrease is due to customer inventory normalization in our automation and engineered solutions core businesses."},{"id":"e18","location":"2025 Form 10-K, filed 2026-02-17; annual organic, acquisition and currency order-growth components","sourceId":"filing-1","excerpt":"The increase in orders was due to a 4% increase from acquisitions, a 4% organic order increase, as well as a 3% favorable effect of foreign currency translation."},{"id":"e19","location":"June 2026 Form 10-Q, filed 2026-08-04; targeted pricing and other tariff mitigation initiatives","sourceId":"filing-2","excerpt":"Our businesses have been proactive in addressing the impacts of tariffs, including targeted pricing initiatives, strategic adjustments to our global supply chains, and leveraging our worldwide manufacturing footprint to localize production and adapt to changing demand patterns."},{"id":"e20","location":"June 2026 Form 10-Q, filed 2026-08-04; realized first-half tariff impact and prospective uncertainty","sourceId":"filing-2","excerpt":"While recent tariff-related changes did not have a material impact on our results of operations for the six months ended June 30, 2026, as the situation continues to evolve, we cannot be certain of the outcome, which could adversely impact demand for our products, costs, inflation, customers, suppliers, and the overall global economy."},{"id":"e21","location":"2025 Form 10-K, filed 2026-02-17; contractual discounts, rebates and early-payment options","sourceId":"filing-1","excerpt":"The Company has certain contracts with variable consideration in the form of volume discounts, rebates and early payment options, which may affect the transaction price used as the basis for revenue recognition."},{"id":"e22","location":"2025 Form 10-K, filed 2026-02-17; 2025 versus 2024 segment operating income as a percentage of net sales","sourceId":"filing-1","excerpt":"Segment operating income, as a percentage of net sales, increased to 27.4% in 2025, compared with 27.2% in 2024."},{"id":"e23","location":"June 2026 Form 10-Q, filed 2026-08-04; second-quarter reported segment operating margins","sourceId":"filing-2","excerpt":"Segment operating margins, as a percentage of net sales, decreased to 27.3% for the second quarter of 2026, compared with 27.5% for the second quarter of 24 Table of Contents 2025."},{"id":"e24","location":"June 2026 Form 10-Q, filed 2026-08-04; segment margin change excluding recent acquisitions and acquisition-related costs","sourceId":"filing-2","excerpt":"Excluding the dilutive impact of recent acquisitions and acquisition-related costs, segment operating margins increased 140 basis points compared to the second quarter of 2025 due to the sales increase discussed above, as well as continued benefits from the Company's Operational Excellence initiatives."},{"id":"e25","location":"2024 Form 10-K, filed 2025-02-20; segment margin improvement excluding 2023 acquisitions and Paragon integration costs","sourceId":"filing-4","excerpt":"Excluding the dilutive impact of the 2023 acquisitions and the Paragon integration costs, segment operating margins increased 130 basis points compared to 2023, due to the continued benefits from the Company's Operational Excellence initiatives."},{"id":"e26","location":"June 2026 Form 10-Q, filed 2026-08-04; second-quarter integration costs and operating-margin impact","sourceId":"filing-2","excerpt":"Operating income and operating margins for the second quarter of 2026 included $16.2 million of acquisition-related integration costs related to the FARO, LKC, and First Aviation acquisitions (\"recent acquisitions\"), which negatively impacted operating margins by 80 basis points."},{"id":"e27","location":"2025 Form 10-K, filed 2026-02-17; annual operating cash generation","sourceId":"filing-1","excerpt":"•Cash provided by operating activities totaled $1,801.8 million in 2025."},{"id":"e28","location":"2025 Form 10-K, filed 2026-02-17; actual acquisition spending net of acquired cash","sourceId":"filing-1","excerpt":"In 2025, the Company paid $933.2 million, net of cash acquired, to purchase Kern Microtechnik and FARO Technologies, compared to $117.5 million, net of cash acquired, to purchase Virtek Vision International in 2024."},{"id":"e29","location":"2025 Form 10-K, filed 2026-02-17; annual share repurchases","sourceId":"filing-1","excerpt":"Under its share repurchase program, the Company repurchased approximately 2,306,500 shares of its common stock for $443.0 million in 2025 and approximately 1,258,200 shares of its common stock for $223.1 million in 2024."},{"id":"e30","location":"2025 Form 10-K, filed 2026-02-17; year-end outstanding share counts","sourceId":"filing-1","excerpt":"The number of shares outstanding at December 31, 2025 was 229.0 million shares, compared with 230.7 million shares at December 31, 2024."},{"id":"e31","location":"June 2026 Form 10-Q, filed 2026-08-04; unaudited first-half cash flows, in thousands, including investment, borrowing and equity activity","sourceId":"filing-2","excerpt":"Condensed Consolidated Statement of Cash Flows (In thousands) (Unaudited) Six months ended June 30, 2026 2025 Cash provided by (used for): Operating activities: Net income $ 806,253 $ 710,125 Adjustments to reconcile net income to total operating activities: Depreciation and amortization 211,421 214,068 Deferred income taxes (8,362) (39,069) Share-based compensation expense 23,600 22,313 Loss (Gain) on sale of facilities — (91) Net change in assets and liabilities, net of acquisitions (77,450) (121,101) Pension contributions (2,535) (3,021) Other, net (17,717) (6,590) Total operating activities 935,210 776,634 Investing activities: Additions to property, plant and equipment (57,479) (52,338) Purchases of businesses, net of cash acquired (424,484) (104,110) Proceeds from sale of facilities — 200 Other, net 473 521 Total investing activities (481,490) (155,727) Financing activities: Net change in short-term borrowings (208,689) (202,653) Repayments of long-term borrowings — (50,000) Repurchases of common stock (28,100) (18,122) Cash dividends paid (155,651) (142,960) Proceeds from stock option exercises 20,800 12,343 Debt financing costs (21,773) — Other, net (14,695) (8,016) Total financing activities (408,108) (409,408) Effect of exchange rate changes on cash and cash equivalents (8,117) 34,214 Increase (decrease) in cash and cash equivalents 37,495 245,713 Cash and cash equivalents: Beginning of period 457,951 373,999 End of period $ 495,446 $ 619,712 See accompanying notes."},{"id":"e32","location":"June 2026 Form 10-Q, filed 2026-08-04; announced approximately $5.0 billion Indicor portfolio acquisition agreement","sourceId":"filing-2","excerpt":"On May 5, 2026, the Company announced that it has entered into a definitive agreement to acquire a portfolio of instrumentation business from Indicor, LLC (\"Indicor Instrumentation\") in an all-cash transaction valued at approximately $5.0 billion."},{"id":"e33","location":"June 2026 Form 10-Q, filed 2026-08-04; acquisition closing conditions and expected timing","sourceId":"filing-2","excerpt":"The transaction is subject to customary closing conditions, including applicable regulatory approvals, and is expected to close in the second half of 2026."},{"id":"e34","location":"June 2026 Form 10-Q, filed 2026-08-04; up to $4.0 billion term facility and tranche maturities","sourceId":"filing-2","excerpt":"The Term Loan Agreement provides for a senior unsecured term loan facility of up to $4.0 billion, consisting of three tranches: $1.625 billion maturing three years after funding, $1.625 billion maturing four years after funding, and $750 million maturing five years after funding."},{"id":"e35","location":"June 2026 Form 10-Q, filed 2026-08-04; no term-loan borrowings outstanding at June 30, 2026","sourceId":"filing-2","excerpt":"At June 30, 2026, the Company had no borrowings outstanding under the term loans."},{"id":"e36","location":"2026 proxy, filed 2026-03-11; performance-unit proportions of target long-term incentives","sourceId":"filing-3","excerpt":"Performance-based restricted stock units comprise 55% of the target long-term incentive award for the CEO, and 50% for the other named executive officers."},{"id":"e37","location":"2026 proxy, filed 2026-03-11; certified earned 2023 performance awards distinguished from target awards","sourceId":"filing-3","excerpt":"The following table shows the number of performance-based restricted stock units to be earned upon achievement of target performance under the terms of the 2024 and 2025 awards, the number of performance-based restricted stock units earned (102%) under the terms of the 2023 awards as certified by the Compensation Committee in early 2026 and the respective value of each award as of the most recent fiscal year-end."},{"id":"e38","location":"2026 proxy, filed 2026-03-11; measures actually used to link executive compensation and performance","sourceId":"filing-3","excerpt":"The most important performance measures used to link executive compensation and company performance during the most recently completed fiscal year, sorted alphabetically, were:\nAdjusted Earnings Per Share\nRelative Total Shareholder Return\nReturn on Tangible Capital\n50\nOTHER BUSINESS\nWe are not aware of any other matters that will be presented at the annual meeting."},{"id":"e39","location":"2026 proxy, filed 2026-03-11; named executive officers' ownership-guideline compliance as of December 31, 2025","sourceId":"filing-3","excerpt":"As of December 31, 2025, all of our named executive officers are in compliance with the stock ownership guidelines."},{"id":"e40","location":"2026 proxy, filed 2026-03-11; unvested restricted stock and units count toward ownership requirements","sourceId":"filing-3","excerpt":"Unvested restricted stock/units count towards stock ownership."},{"id":"e41","location":"2026 proxy, filed 2026-03-11; performance units and unexercised options excluded from executive ownership requirements","sourceId":"filing-3","excerpt":"Neither performance-based restricted stock units nor unexercised stock options count towards executive officer stock ownership."},{"id":"e42","location":"2026 proxy, filed 2026-03-11; existing compensation governance, clawback, hedging and pledging policies","sourceId":"filing-3","excerpt":"What We Do\n✓\nStrong alignment between pay and performance\n✓\nLarge majority of executive compensation is at-risk and variable\n✓\nLarge majority of variable compensation is delivered as long-term incentives\n✓\nAll long-term incentives are denominated and delivered in equity\n✓\nStock ownership requirements for all executive officers\n✓\nMinimum vesting requirements for equity awards per our equity plan\n✓\nCaps on annual bonuses to avoid excessive short-term focus and potentially adverse risk-taking\n✓\nIndependent external compensation benchmarking is performed annually to ensure competitiveness\n✓\nUse of an independent consultant to advise the Compensation Committee\n✓\nClawback policy applicable to current and former executive officers\nWhat We Don’t Do\n✘\nNo “single trigger” equity vesting upon change of control\n✘\nNo excise tax gross-ups on change of control payments\n✘\nNo excessive perquisites\n✘\nNo hedging of our common stock by our officers and Directors\n✘\nNo pledging of our common stock by our officers and Directors\n✘\nNo discounting, reloading or repricing of stock options without stockholder approval\n✘\nNo evergreen provision in our equity plan\n2025 Compensation\nCompensation Objectives\nThe compensation paid or awarded to our named executive officers for 2025 was designed to meet the following objectives:"},{"id":"e43","location":"June 2026 Form 10-Q, filed 2026-08-04; actual performance restricted stock activity and performance-assumption footnote","sourceId":"filing-2","excerpt":"Performance Restricted Stock Units The following is a summary of the Company’s non-vested performance restricted stock activity and related information: Shares Weighted Average Grant Date Fair Value (In thousands) Non-vested performance restricted stock outstanding at December 31, 2025 240 $ 166.06 Granted 79 212.77 Performance assumption change 1 2 138.46 Vested (77) 138.46 Forfeited (5) 182.76 Non-vested performance restricted stock outstanding at June 30, 2026 239 $ 189.80 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics."},{"id":"e44","location":"2026 proxy, filed 2026-03-11; seven of eight directors determined independent","sourceId":"filing-3","excerpt":"Accordingly, seven of our eight Directors are “independent” Directors based on an affirmative determination by our Board in accordance with the listing standards of the NYSE and the SEC rules."},{"id":"e45","location":"2026 proxy, filed 2026-03-11; lead independent director responsibilities","sourceId":"filing-3","excerpt":"✓ Lead independent Director chairs meetings of the independent Directors and is a liaison between the independent Directors and our Chairman and CEO."},{"id":"e46","location":"2026 proxy, filed 2026-03-11; classified board and staggered three-year terms","sourceId":"filing-3","excerpt":"The Board is divided into three classes with staggered terms of three years each, so that the term of one class expires at each Annual Meeting of Stockholders."},{"id":"e47","location":"2026 proxy, filed 2026-03-11; combined chairman and CEO","sourceId":"filing-3","excerpt":"The Board currently believes that a combined Chairman and CEO is in the best interest of our company as our Chairman and CEO serves as a bridge between management and the Board, ensuring that both groups act with a common vision and strategy."},{"id":"e48","location":"2026 proxy, filed 2026-03-11; one-share-one-vote rights and absence of poison pill","sourceId":"filing-3","excerpt":"✓ One share, one vote. ✓ No poison pill."},{"id":"e49","location":"Form 8-K, filed 2026-05-08; independence of newly appointed director","sourceId":"filing-12","excerpt":"Mr. Stanage joins the Board as an independent director."},{"id":"e50","location":"Form 8-K, filed 2026-05-08; director appointment effective May 7, 2026 and specified term","sourceId":"filing-12","excerpt":"Nick L. Stanage was appointed to the Board of Directors of AMETEK, Inc., or the “Company” effective May 7, 2026 to serve as a Class III Director until the 2027 Annual Meeting."}],"changes":["Retain the narrow verdict and existing numerical grades after reassessing the current catalog; realized_pricing remains null.","Correct the previous ownership-evidence limitation: the current catalog explicitly reports named executive officers' compliance with ownership guidelines at December 31, 2025. Unvested restricted stock counts toward those requirements.","Continue to exclude the conditional Indicor acquisition's projected benefits from demonstrated advantages; the supplied passages do not establish its subsequent closing."],"limitations":["All selected evidence is issuer disclosure. Technology leadership and market-share assertions lack quantified competitor comparisons; operating results corroborate commercial relevance but do not establish relative superiority by themselves.","No entities are identified as competitors in the supplied competition passages. Named acquisition targets, advisers and shareholders are not treated as competitors.","Organic growth does not isolate price, physical volume or mix. Targeted pricing initiatives disclose action, not realized price increases or customer acceptance.","Firm orders establish contractual commitment for a portion of demand, not portfolio-wide switching costs, customer-level retention or renewal rates.","The latest supplied operating period ends June 30, 2026. Filing dates are treated as filed dates, not as later operating updates. Generic risks are prospective possibilities rather than demonstrated competitive losses.","Evidence does not establish network effects, structural cost superiority or efficient-scale entry barriers. High margins alone do not support the moat verdict."],"qualityAssessments":[{"category":"moat","checks":[{"criterion":"structural_advantage","grade":2,"rationale":"Proprietary technology, differentiated niche products and actual engineering spending support an intangible-asset advantage. Organic order and sales growth corroborate commercial relevance. However, relative market-share strength remains an issuer assertion without quantified comparisons, and barriers preventing competitors from replicating these capabilities are incompletely established.","evidenceIds":["e1","e2","e3","e4","e6","e14","e15"]},{"criterion":"durability","grade":2,"rationale":"Engineering spending across 2021–2023, subsequent product introductions and firm orders deliverable over two to three years support persistence. Maintaining technological advantages requires continued investment. No patent or trademark group is essential, and the disclosures do not demonstrate exceptional long-term exclusion of substitutes or competitors.","evidenceIds":["e3","e4","e5","e10","e11","e12","e13"]},{"criterion":"customer_dependency","grade":2,"rationale":"Remaining obligations beyond one year rose from $627.4 million at December 31, 2025 to $747.7 million at June 30, 2026 and represent firm, non-cancelable orders. This demonstrates bounded contractual commitment. It does not establish expensive replacement, qualification barriers, customer concentration or portfolio-wide operational dependency.","evidenceIds":["e11","e12","e13"]},{"criterion":"erosion_resilience","grade":2,"rationale":"Organic orders increased 4% in 2025 and 25% in second-quarter 2026; first-half tariffs had no material operating impact. The 2024 organic order contraction was attributed to inventory normalization, not established competitive displacement. Copying and substitution remain prospective erosion risks, with insufficient comparative evidence for stronger resilience.","evidenceIds":["e18","e14","e20","e16","e17","e7","e8","e9"]}]},{"category":"pricing_power","checks":[{"criterion":"realized_pricing","grade":null,"rationale":"Targeted pricing initiatives show management acted on prices, but the supplied passages do not disclose achieved price changes, concessions or a price contribution separated from volume and mix. Organic sales growth and tariff resilience cannot isolate realized pricing because supply-chain changes and operating efficiencies also contributed.","evidenceIds":["e19","e20","e15","e24"]},{"criterion":"retention","grade":2,"rationale":"Growing firm long-term obligations and organic demand provide indirect evidence of continuing customer demand. They do not identify repeat customers or establish retention after repricing. The earlier organic order contraction also shows demand variability, although its inventory-normalization explanation does not demonstrate customer defections.","evidenceIds":["e11","e12","e14","e18","e16","e17"]},{"criterion":"margin_resilience","grade":3,"rationale":"Segment margins improved in 2025, with underlying improvements also disclosed for 2024 and second-quarter 2026. Tariffs had no material first-half impact. Reported second-quarter segment margins nevertheless slipped and integration costs were real. This demonstrates strong operating resilience, while efficiency, acquisition effects and sales growth prevent attributing it solely to pricing.","evidenceIds":["e22","e25","e23","e24","e26","e20"]},{"criterion":"contractual_freedom","grade":2,"rationale":"Targeted pricing initiatives demonstrate some practical discretion to adjust prices. Certain contracts also provide volume discounts, rebates and early-payment options that affect transaction prices. These support a mixed assessment; the scope of unilateral repricing rights, escalation provisions and restrictions across the portfolio is not disclosed.","evidenceIds":["e19","e21"]}]},{"category":"strong_management","checks":[{"criterion":"capital_discipline","grade":2,"rationale":"Actual cash generation, acquisition spending, repurchases, lower year-end shares and first-half borrowing reductions support discipline. Acquisition returns are not separately demonstrated. The conditional approximately $5 billion Indicor agreement and up to $4 billion term facility materially increase prospective exposure; term loans remained undrawn at June 30, 2026.","evidenceIds":["e27","e28","e29","e30","e31","e32","e33","e34","e35"]},{"criterion":"incentive_alignment","grade":3,"rationale":"Substantial performance-unit incentives, certified earned awards and actual vesting demonstrate implementation. Compensation uses relative shareholder return and return on tangible capital. Reported ownership compliance, clawback and trading restrictions strengthen alignment. Unvested restricted stock counts toward ownership requirements, and these mechanisms do not prove exceptional incentive effectiveness.","evidenceIds":["e36","e37","e38","e39","e40","e41","e42","e43"]},{"criterion":"execution","grade":3,"rationale":"Organic sales and order growth, cash generation and underlying margin improvement provide strong indirect operating evidence of execution. Acquisition contributions are distinguished from organic growth. The earlier order contraction and realized integration costs temper the assessment; projected benefits from the pending Indicor transaction are excluded.","evidenceIds":["e14","e15","e18","e24","e27","e31","e16","e17","e26","e33"]},{"criterion":"governance","grade":2,"rationale":"The March proxy established seven independent directors out of eight, a lead independent director, equal voting rights and no poison pill. A subsequently appointed director was explicitly independent. Combined chairman and CEO roles and staggered board terms offset these safeguards; a complete subsequently reconciled board count is not supplied.","evidenceIds":["e44","e45","e46","e47","e48","e49","e50"]}]}],"financialAssessments":[],"qualityPolicy":"quality-scores-3","sourcePolicy":"issuer-evidence-9","basisHash":"95f94dbc37034d7f1724de8bd35178988f2d7678aa922185603cc9020707cfac","updatedAt":"2026-10-21T18:50:27.090Z","sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000016/ame-20251231.htm","publishedAt":"2026-02-17","sha256":"a4c2fb3e36db8381c9ba518fa629f927b019f035586e2ee114d6a7d5e6d25850","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000175/ame-20260630.htm","publishedAt":"2026-08-04","sha256":"8ea92b0aaba4db31e7884311777d274b87d9a6e6e26c7af8a57d848ca3878539","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000062/ame-20260311.htm","publishedAt":"2026-03-11","sha256":"d368bfe222d966bb2da200ab04169697a396d0c364fbac7cff7a12cffeb83b5c","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786825000012/ame-20241231.htm","publishedAt":"2025-02-20","sha256":"5275d94733255ebac1959c20bf2928c6b317848bca0ddff4969a6bfa9aced638","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786824000009/ame-20231231.htm","publishedAt":"2024-02-22","sha256":"8db8c120fa18fa2966a82790904de3e1a8b59cc0c8fd5e283fecdb7af132ea0a","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-11","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000157/ame-20260507.htm","publishedAt":"2026-05-11","sha256":"069f7b0d3d1c5c94b9e6e2ea16fd42b7161b8ee049951b1923b2ad67df0d160d","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-12","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000151/ame-20260507.htm","publishedAt":"2026-05-08","sha256":"a645a82499a8e9898b01e4c5a42dcc7aea53cf9fffb089e460a578225c3fc2bb","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-8","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000144/ame-20260331.htm","publishedAt":"2026-04-30","sha256":"b8bbb1e1b698e18c276260f59ee2b6cbe065b6c87ad194dcdc55da8d9b109de4","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000173/ametek8kexhibit99108042026.htm","publishedAt":"2026-08-04","sha256":"9e67d9bbf92af3cd4ede403f5bd708462ea1991879ae2345559362b997c835c1","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-7","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000141/ametek8kexhibit99104302026.htm","publishedAt":"2026-04-30","sha256":"70025387f5391ab25a74ac02315460531255e79edfb859124787918b61dd51e3","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-13","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000141/ametek8kexhibit99204302026.htm","publishedAt":"2026-04-30","sha256":"e3354607e0573c960e2266967276eac174570470757646f84f5a1f3c46d858ed","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-9","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000006/ametek8kexhibit99102032026.htm","publishedAt":"2026-02-03","sha256":"47f422e23069436c6051bf2a96134938140e7ff0529aa60d944742b1a306e5be","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-10","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000006/ametek8kex99202-03x2026.htm","publishedAt":"2026-02-03","sha256":"8bb63f587109a7cfdbc8f00c989dd5d48fceff2675168aaef62e62b132a40ace","citationPolicy":"numeric-blocks-2","dateKind":"filed"}],"model":"gpt-6.1-sol","providerId":"codex:ae53e2591443b2d66a266715d56e1f94856ae43166cc1fc0e9e6403e3d6abf64","usage":{"input_tokens":87460,"cached_input_tokens":0,"cache_write_input_tokens":0,"output_tokens":5101,"reasoning_output_tokens":343},"basisSupplement":{"previousHash":"c7c3523b980021bc8e7bd3f2950968cd7239112d314393cb3af94f373e71c44c","checkedAt":"2026-10-29T11:34:56.472Z","rule":"dated historical and empty core inputs only; known observations, prior evidence and research date retained"}},"signals":[{"period":"2021","end":"2021-12-31","values":{"gross_margin":34.48317267386326,"operating_margin":23.594459510964903,"roic":13.061455419514568,"fcf_margin":18.92695123459528,"sbc_revenue":0.8312067723979423},"issues":{"pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%."}},{"period":"2022","end":"2022-12-31","values":{"gross_margin":34.87941689577971,"operating_margin":24.399393223023058,"roic":13.106764975668463,"fcf_margin":16.427332278681675,"sbc_revenue":0.7702588232233645},"issues":{"pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%."}},{"period":"2023","end":"2023-12-31","values":{"gross_margin":36.144960928914124,"operating_margin":25.882551785294723,"roic":13.199047896873836,"fcf_margin":24.23918629063431,"sbc_revenue":0.700308475886584},"issues":{"software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%."}},{"period":"2024","end":"2024-12-31","values":{"gross_margin":35.677896265476484,"operating_margin":25.637744590977324,"roic":12.819210161129323,"fcf_margin":24.517056177768044,"sbc_revenue":0.6895513442959267},"issues":{"software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","roiic":"Invested capital did not increase versus the prior year. ROIIC requires a positive increase.","roic_wacc":"Enter a WACC assumption from 0 to 100%."}},{"period":"2025","end":"2025-12-31","values":{"gross_margin":36.041037594870836,"operating_margin":25.81120198629504,"roic":13.204244868626484,"fcf_margin":22.584634533494675,"sbc_revenue":0.6454026663005958},"issues":{"pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%."}}],"sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000016/ame-20251231.htm","publishedAt":"2026-02-17","sha256":"a4c2fb3e36db8381c9ba518fa629f927b019f035586e2ee114d6a7d5e6d25850","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000175/ame-20260630.htm","publishedAt":"2026-08-04","sha256":"8ea92b0aaba4db31e7884311777d274b87d9a6e6e26c7af8a57d848ca3878539","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000062/ame-20260311.htm","publishedAt":"2026-03-11","sha256":"d368bfe222d966bb2da200ab04169697a396d0c364fbac7cff7a12cffeb83b5c","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786825000012/ame-20241231.htm","publishedAt":"2025-02-20","sha256":"5275d94733255ebac1959c20bf2928c6b317848bca0ddff4969a6bfa9aced638","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786824000009/ame-20231231.htm","publishedAt":"2024-02-22","sha256":"8db8c120fa18fa2966a82790904de3e1a8b59cc0c8fd5e283fecdb7af132ea0a","dateKind":"filed","citationPolicy":"numeric-blocks-2"},{"id":"filing-11","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000157/ame-20260507.htm","publishedAt":"2026-05-11","sha256":"069f7b0d3d1c5c94b9e6e2ea16fd42b7161b8ee049951b1923b2ad67df0d160d","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-12","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000151/ame-20260507.htm","publishedAt":"2026-05-08","sha256":"a645a82499a8e9898b01e4c5a42dcc7aea53cf9fffb089e460a578225c3fc2bb","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-8","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000144/ame-20260331.htm","publishedAt":"2026-04-30","sha256":"b8bbb1e1b698e18c276260f59ee2b6cbe065b6c87ad194dcdc55da8d9b109de4","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000173/ametek8kexhibit99108042026.htm","publishedAt":"2026-08-04","sha256":"9e67d9bbf92af3cd4ede403f5bd708462ea1991879ae2345559362b997c835c1","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-7","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000141/ametek8kexhibit99104302026.htm","publishedAt":"2026-04-30","sha256":"70025387f5391ab25a74ac02315460531255e79edfb859124787918b61dd51e3","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-13","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000141/ametek8kexhibit99204302026.htm","publishedAt":"2026-04-30","sha256":"e3354607e0573c960e2266967276eac174570470757646f84f5a1f3c46d858ed","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-9","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000006/ametek8kexhibit99102032026.htm","publishedAt":"2026-02-03","sha256":"47f422e23069436c6051bf2a96134938140e7ff0529aa60d944742b1a306e5be","citationPolicy":"numeric-blocks-2","dateKind":"filed"},{"id":"filing-10","url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000006/ametek8kex99202-03x2026.htm","publishedAt":"2026-02-03","sha256":"8bb63f587109a7cfdbc8f00c989dd5d48fceff2675168aaef62e62b132a40ace","citationPolicy":"numeric-blocks-2","dateKind":"filed"}],"history":[{"version":9,"updatedAt":"2026-10-31T09:05:44.078Z","verdict":"narrow","value":null},{"version":8,"updatedAt":"2026-10-28T04:14:07.262Z","verdict":"narrow","value":null},{"version":7,"updatedAt":"2026-10-24T22:27:09.725Z","verdict":"narrow","value":null},{"version":6,"updatedAt":"2026-10-23T18:52:12.943Z","verdict":"narrow","value":null},{"version":5,"updatedAt":"2026-10-22T22:17:09.215Z","verdict":"narrow","value":null},{"version":4,"updatedAt":"2026-10-19T13:57:15.039Z","verdict":"narrow","value":null},{"version":3,"updatedAt":"2026-10-18T16:35:43.872Z","verdict":"narrow","value":null},{"version":2,"updatedAt":"2026-10-18T02:27:49.793Z","verdict":"narrow","value":null},{"version":1,"updatedAt":"2026-10-18T02:18:02.026Z","verdict":null,"value":null}],"hasRequested":false,"requestStatus":"completed","researchIssue":null,"archivedMoat":null,"scope":"supported_catalog"}